Skip to content

13F-HR/A filed by Birchview Capital, LP

Birchview Capital, LP filed this 13F-HR/A for the quarter ended 2022-09-30, filed 2022-11-28, with 60 holding rows worth $142,011,000.

Accession
0001618205-22-000005
Filed
2022-11-28
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, amendment of type restatement, 60 entries on the cover page, a total value of $142,011,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $142,011,000 with VALUE read as thousands by filing date, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Bristol-Myers Squibb Company110122108COM727,785$51,738,000thousands by filing date
ELUTIA INC05479K106CL A COM1,418,123$10,210,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM85,240$9,053,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock118,945$7,212,000thousands by filing date
QUIDEL CORP74838J101COM61,306$4,382,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM249,400$4,080,000thousands by filing date
OVINTIV INC69047Q102COM84,200$3,873,000thousands by filing date
Accelerate Diagnostics00430H102COM2,252,388$3,424,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock15,000$3,141,000thousands by filing date
BIODESIX INC09075X108COM2,370,071$3,010,000thousands by filing date
CONTINENTAL RES INC212015101COM38,600$2,579,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK264,843$2,272,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK117,000$2,265,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM14,730$2,227,000thousands by filing date
HARROW INC415858109COM180,000$2,173,000thousands by filing date
MASIMO CORP COM574795100Stock15,280$2,157,000thousands by filing date
PHREESIA INC71944F106COM82,700$2,107,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock159,088$1,906,000thousands by filing date
Ventyx Biosciences Inc92332V107Common Stock45,000$1,571,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM269,332$1,471,000thousands by filing date
CORCEPT THERAPEUTICS INC218352102COM50,000$1,282,000thousands by filing date
INHIBRX INC45720L107COM70,448$1,265,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW25,000$1,211,000thousands by filing date
AVEO PHARMACEUTICALS INC053588307COM140,000$1,152,000thousands by filing date
ALKERMES PLCG01767105SHS50,000$1,117,000thousands by filing date
DOCGO INC256086109COM110,000$1,091,000thousands by filing date
CHEMOCENTRYX INC16383L106COM20,000$1,033,000thousands by filing date
EQUITRANS MIDSTREAM CORP NPV294600101COM133,050$995,000thousands by filing date
2SEVENTY BIO INC COMMON STOCK901384107Stock59,833$871,000thousands by filing date
PIONEER NATURAL RESOURCES CO723787107COM3,800$823,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM12,000$820,000thousands by filing date
INARI MED INC45332Y109COM10,000$726,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK150,000$717,000thousands by filing date
ARVINAS INC04335A105COM15,000$667,000thousands by filing date
BLUEBIRD BIO INC09609G100COM98,000$620,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM40,000$580,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock4,000$501,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM40,000$500,000thousands by filing date
SILK ROAD MEDICAL INC82710M100COMMON STOCK10,000$450,000thousands by filing date
IVERIC BIO INC46583P102COM25,000$449,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM128,000$410,000thousands by filing date
SOLENO THERAPEUTICS INC834203101COM245,127$409,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM38,000$397,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A30,000$385,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock10,000$361,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM25,114$322,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM38,000$320,000thousands by filing date
XENCOR INC98401F105COMMON STOCK12,300$320,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM2,500$276,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock20,000$252,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM15,000$193,000thousands by filing date
Inflarx NvN44821101COM70,000$185,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM20,000$134,000thousands by filing date
ALPHATEC HLDGS INC02081G201COM NEW10,000$87,000thousands by filing date
YIELD10 BIOSCIENCE INC98585K102COM18,750$56,000thousands by filing date
LAIRD SUPERFOOD INC50736T102CMN28,000$51,000thousands by filing date
ANGION BIOMEDICA CORP03476J107COM54,392$50,000thousands by filing date
CONTRAFECT CORP212326102COM200,000$34,000thousands by filing date
SIENTRA INC82621J105COM40,000$26,000thousands by filing date
ASPIRA WOMENS HEALTH INC04537Y109COM60,070$22,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001618205-22-000004 superseded2022-11-07acceptance time not in the bulk data set
13F-HR/A 0001618205-22-000005this filing2022-11-28acceptance time not in the bulk data set